Citation: | Jinyu LI, Liangsheng FENG, Yang GAO, Yu LI, Bangxu WU, Yingying ZOU. Research Progress of DRD1 in Neurological Disorders and Functions[J]. Journal of Kunming Medical University, 2024, 45(5): 1-7. doi: 10.12259/j.issn.2095-610X.S20240501 |
[1] |
Sioka C,Fotopoulos A,Kyritsis A P. Recent advances in PET imaging forevaluation of Parkinson's disease[J]. Eur J Nucl Med Mol Imaging,2010,37(8):1594-1603. doi: 10.1007/s00259-009-1357-9
|
[2] |
Wei X,Ma T,Cheng Y,et al. Dopamine D1 or D2 receptor-expressing neurons in the central nervous system[J]. Addict Biol,2018,23(2):569-584. doi: 10.1111/adb.12512
|
[3] |
Zang X,Cheng Z Y,Sun Y,et al. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ1-42-induced cognitive impairment[J]. Prog Neuropsychopharmacol Biol Psychiatry,2018,2(81):250-261.
|
[4] |
Kim M,Custodio R J,Lee H J,et al. Per2 Expression regulates the spatial working memory of mice through DRD1-PKA-CREB signaling[J]. Mol Neurobiol,2022,59(7):4292-4303. doi: 10.1007/s12035-022-02845-z
|
[5] |
C Missale, S R Nash, S W Robinson, et al. Dopamine receptors: From structure to function[J]. Physiol Rev,1998,78(1):189-225.
|
[6] |
Trzaskowski B,Latek D,Yuan S,et al. Action of molecular switches in GPCRs-theoretical and experimental studies[J]. Curr Med Chem,2012,19(8):1090-1109.
|
[7] |
曹国祥. 多巴胺受体显像剂的研究概况[J]. 国外医学(放射医学核医学分册),1999,23(2):65-67
|
[8] |
Wen X S,Chen X M,Rong F,et al. The regulation of SKF38393 on the dopamine and D1 receptor expression in hippocampus during chronic REM sleep restriction[J]. CNS Neurosci Ther,2013,19(9):730-733. doi: 10.1111/cns.12140
|
[9] |
乔晋萍,乔洪文,武仙英,等. 多巴胺神经系统显像分子探针研究[J]. 生命的化学,2014,34(2):154-165.
|
[10] |
Gouveri E,Katotomichelakis M,Gouveris H,et al. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease?[J]Angiology,2014,65(10): 869-876.
|
[11] |
李瑞,范运龙,刘海鹰,等. 多巴胺D1受体在小鼠大脑皮层的空间分布研究[J]. 神经解剖学杂志,2019,35(3):229-235.
|
[12] |
De Bundel D,Femen í a T,DuPont C M,et al. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine[J]. Int J Neuropsychopharmacol,2013,16(9):2041-51. doi: 10.1017/S1461145713000370
|
[13] |
Liu A,Ding S. Anti-inflammatory Effects of Dopamine in lipopolysaccharide (LPS)-stimulated RAW264.7 cells via inhibiting NLRP3 inflammasome activation[J]. Ann Clin Lab Sci,2019,49(3):353-360.
|
[14] |
Seamans J K,Yang C R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex[J]. Prog Neurobiol,2004,74(1):1-57. doi: 10.1016/j.pneurobio.2004.05.006
|
[15] |
张国炳, 陈峻严, 孙文栋,等. 多巴胺D1受体基因(-48A/G)多态性与额叶挫裂伤后认知障碍相关性[J]. 中华实验外科杂志,2016,33(4):993-996.
|
[16] |
J M Beaulieu,S Espinoza,R R Gainetdinov. Dopamine receptors - IUPHAR review 13[J]. Britisch Journal of Pharmacology,2015,172(1): 1-23.
|
[17] |
王功伍,蔡景霞. 海马-前额叶神经回路与工作记忆[J]. 动物学研究,2010,31(1):50-56.
|
[18] |
Tsang J,Fullard J F,Giakoumaki S G,et al. The relationship between dopamine receptor D1 and cognitive performance[J]. NPJ Schizophr,2015,4(1):14002.
|
[19] |
El-Ghundi M,Fletcher P J,Drago J,et al. Spatiallearning deficit in dopamine D(1) receptor knockout mice[J]. Eur J Pharmacol,1999,383(2):95-106. doi: 10.1016/S0014-2999(99)00573-7
|
[20] |
Tractenberg S G,Orso R,Creutzberg K C,et al. Vulnerable and resilient cognitive performance related to early life stress: The potential mediating role of dopaminergic receptors in the medial prefrontal cortex of adult mice[J]. Int J Dev Neurosci,2020,80(1):13-27. doi: 10.1002/jdn.10004
|
[21] |
胡一文,王高华,顾剑. 精神分裂症患者多巴胺D1受体基因-48A/G多态性与认知功能的关系[J]. 中国神经精神疾病杂志,2006,32(6):523-526. doi: 10.3969/j.issn.1002-0152.2006.06.009
|
[22] |
李凡,舒斯云,包新民. 多巴胺受体的结构和功能[J]. 中国神经科学杂志,2003,19(6):405-410.
|
[23] |
Smith, Y Raju, D V Pare, et al. The thalamostriatal system: A highly specific network of the basal ganglia circuitry[J]. Trends Neurosci,2004,27(9):520-527.
|
[24] |
Darmopil S, Mart í n A B, De Diego I R, et al. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation[J]. Biol Psychiatry,2009,66(6):603-613.
|
[25] |
Reid K M,Steel D,Nair S,et al. Loss-of-function variants in DRD1 in infantile Parkinsonism-dystonia[J]. Cells,2023,12(7):1046.
|
[26] |
Toma C,Herv á s A,Balmaña N,et al. Neurotransmitter systems and neurotrophic factors in autism: Association study of 37 genes suggests involvement of DDC[J]. World J Biol Psychiatry,2013,14(7):516-527. doi: 10.3109/15622975.2011.602719
|
[27] |
Cartier E,Hamilton P J,Belovich A N,et al. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors[J]. EBio Medicine,2015,2(2):135-146. doi: 10.1016/j.ebiom.2015.01.007
|
[28] |
Corrales E,Navarro A,Cuenca P,et al. Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression[J]. Psychiatry Res,2016,244(11):71-77.
|
[29] |
Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia[J]. Life Science,1999,65(22):2269-2287.
|
[30] |
Odum A L. Delay discounting: I'm a k,you're a k[J]. J Exp Anal Behav,2011,96(3):427-439. doi: 10.1901/jeab.2011.96-423
|
[31] |
Bickel W K,Jarmolowicz D P,Mueller E T,et al. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: Emerging evidence[J]. Pharmacol Ther,2012,134(3):287-297. doi: 10.1016/j.pharmthera.2012.02.004
|
[32] |
Moses T E H,Burmeister M,Greenwald M K. Heroin delay discounting and impulsivity: Modulation by DRD1 genetic variation[J]. Addict Biol,2020,25(3):e12777. doi: 10.1111/adb.12777
|
[33] |
Ashe M L,Newman M G,Wilson S J. Delay discounting and the use of mindful attention versus distraction in the treatment of drug addiction: A conceptual review[J]. J Exp Anal Behav,2015,103(1):234-248. doi: 10.1002/jeab.122
|
[34] |
Lee W,Ray R,Bergen A W,et al,Thomas P. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers[J]. Pharmacogenet Genomics,2012,22(7):551-4. doi: 10.1097/FPC.0b013e3283539062
|
[35] |
Yan. Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome[J]. Cell,2015,160(1-2):62-73. doi: 10.1016/j.cell.2014.11.047
|
[36] |
Cosentino M,Fietta A M,Ferrari M,et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholaminessubserving an autocrine/paracrine inhibitory functional loop[J]. Blood,2007,109(2):632-642. doi: 10.1182/blood-2006-01-028423
|
[37] |
Ferrari M,Cosentino M,Marino F,et al. Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNAexpression and catecholamine production in human lymphocytes[J]. Biochem Pharmacol,2004,67(5):865-873. doi: 10.1016/j.bcp.2003.10.004
|
[38] |
Tsunoda M. Role of catecholamine metabolism in blood pressure regulation using chemiluminescence reactiondetection[J]. Yakugaku Zasshi,2008,128(11):1589-1594 . doi: 10.1248/yakushi.128.1589
|
[39] |
M ravec B. Role of catecholamine-induced activation of vagal afferent pathways in regulation of sympathoadrenal system activity: Negative feedback loop of stress response[J]. Endocr Regul,2011,45(1):37-41 .
|
[40] |
Nakano K,Higashi T,Takagi R,et al,Matsushita S. Dopaminereleased by dendritic cells polarizes Th2 differentiation[J]. Int Immunol,2009,21(6):645-654. doi: 10.1093/intimm/dxp033
|
[41] |
Zanassi P,Paolillo M,Montecucco A,et al. Pharmacological and molecular evidence for dopamine D(1) receptor expression bystriatal astrocytes in culture[J]. J Neurosci Res,1999,58(4):544-552. doi: 10.1002/(SICI)1097-4547(19991115)58:4<544::AID-JNR7>3.0.CO;2-9
|
[42] |
Zhang X,Zhou Z,Wang D,et al. Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2expression in astrocytes via IP3-dependent Ca2+ signaling[J]. J Neurosci,2009,29(24):7766-7775 . doi: 10.1523/JNEUROSCI.0389-09.2009
|
[43] |
Beaulieu J M,Gainetdinov R R. The physiology,signaling,and pharmacology of dopamine receptors[J]. Pharmacological Reviews,2011,63(1):182-217. doi: 10.1124/pr.110.002642
|
[44] |
Ng J, Barral S, Waddington S N, et al. Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the clinical phenotype and precision medicine approaches[J]. Cells, 2023, 12(13):1737.
Ng J, Barral S, Waddington S N, et al. Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the clinical phenotype and precision medicine approaches[J]. Cells, 2023,12(13):1737.
|
[45] |
张超洁,商亚珍. CREB与阿尔茨海默病[J]. 承德医学院学报,2023,40(3):237-241.
|
[46] |
Brami-Cherrier K,Valjent E,Garcia M,et al. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: A new route to cAMP response element-binding protein phosphorylation[J]. J Neurosci,2002,22(20):8911-8921. doi: 10.1523/JNEUROSCI.22-20-08911.2002
|
[47] |
Monsma F J,Jr.,Mahan L C,et al. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation[J]. Proc Natl Acad Sci USA,1990,87(17):6723-6727. doi: 10.1073/pnas.87.17.6723
|
[48] |
Cosentino M,Kustrimovic N,Ferrari M,et al. cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms[J]. Immunology,2018,153(3):337-341. doi: 10.1111/imm.12843
|
[49] |
D’ SaC ,Duman R S . Antidepressants and neuroplasticity[J]. Bipolar Disord,2002,4(3): 183-194.
|
[50] |
李云峰,杨明,赵毅民,等. 巴戟天寡糖对皮质酮损伤的PC12细胞的保护作用[J]. 中国中药杂志,2000,25(9):39-42.
|
[51] |
李云峰,罗质璞. 丁螺环酮对皮质酮所致PC12细胞损伤的保护作用[J]. 中国药理学与毒理学杂志,2001,15(5):333-336.
|
[52] |
Possemato E, La Barbera L, Nobili A, et al. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases[J]. Ageing Res Rev,2023,87(1):101907.
|
[53] |
Yang C,Kazanietz M G. Divergence and complexities in DAG signaling: Looking beyond PKC[J]. Trends Pharmacol Sci,2003,24(11):602-608. doi: 10.1016/j.tips.2003.09.003
|
[54] |
Felder C C,Jose P A,Axelrod J. The dopamine-1 agonist,SKF 82526,stimulates phospholipase-C activity independent of adenylate cyclase[J]. J Pharmacol Exp Ther,1989,248(1):171-175.
|
[55] |
Berridge M J. Inositol trisphosphate and calcium signalling mechanisms[J]. Biochim Biophys Acta,2009,1793(6):933-940. doi: 10.1016/j.bbamcr.2008.10.005
|
[56] |
Qin D,Liu P,Chen H,et al. Salicylate-induced ototoxicity of spiral ganglion neurons: Ca2+/CaMKII-mediated interaction between NMDA receptor and GABAA receptor[J]. Neurotox Res,2019,35(4):838-847. doi: 10.1007/s12640-019-0006-8
|
[57] |
Zeng C,Villar V A,Yu P,et al. Reactive oxygen species and dopamine receptor function in essential hypertension[J]. Clin Exp Hypertens,2009,31(2):156-178. doi: 10.1080/10641960802621283
|
[58] |
Kansra V,Chen C J,Lokhandwala M F. Dopamine fails to stimulate protein kinase C activity in renal proximal tubules of spontaneously hypertensive rats[J]. Clin Exp Hypertens,1995,17(5):837-845. doi: 10.3109/10641969509033638
|
[59] |
Kim B,Yun J,Park B. Methamphetamine-induced neuronal damage: Neurotoxicity and neuroinflammation[J]. Biomol Ther,2020,28(5):381-388.
|
[60] |
Premoli M, Aria F, Bonini S A, et al. Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment[J]. Life Sci,2019,224(1):120-127.
|
[61] |
Vitale R M, Iannotti F A, Amodeo P. The (poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: Molecular mechanisms and targets[J]. International Journal of Molecular Sciences,2021,22(9):4876.
|
[1] | Xinyi MEN, Jing ZHAO, Yongchun SHEN, Hui JI, Xiuxia WANG. The Relationship between Peripheral Blood Immunoglobulin,Erythrocyte Sedimentation Rate,Homocysteine and the Degree of Central Nervous System Vasculitis in Children and Their Influence on Prognosis. Journal of Kunming Medical University, 2024, 45(12): 1-7. |
[2] | Sheng-qingyu ZHANG, Xiao SHU, Xi-nan WU, Zhi-qiang LI, Hui-xin WU, Yuan ZHANG, Yu-rong JIANG, Shi-jia YANG, Yun-zhen MU. The Effect of 1800 MHz Radio Frequency Electromagnetic Field Exposure on the Expression of GFAP,NCAM and GABA Receptors in Hippocampus of Rats. Journal of Kunming Medical University, 2021, 42(9): 13-19. doi: 10.12259/j.issn.2095-610X.S20210939 |
[3] | Jin Jin Hua , Li Ke Yan , Zhang Ling , Wang Yu Hui , Deng Xiao Ming . . Journal of Kunming Medical University, 2020, 41(02): 16-20. |
[4] | Zhao Heng , Xu Bin , Zhao Guang Zhou , Li Rong Jie , Zhou Bai Ling , Liu Ye , Shi Shu Lan . . Journal of Kunming Medical University, 2020, 41(08): 121-125. |
[5] | Wang Yi Hang , Hong Shi Jun , Zhong Lei Lei , Jie Run Fang , Peng Yan Xia , Li Li Hua . . Journal of Kunming Medical University, 2020, 41(03): 17-21. |
[6] | Chen Zhi Bin , Mo Yan Ping , Yang Yu , Chen Can Kun , Yang Jing Yi , Wan Rui Xue , Fan Zhi Xiang , Long Li . 趋化因子受体CX3CR1基因T280M多态性在云南彝族人群中的分布. Journal of Kunming Medical University, 2017, 38(08): 35-39. |
[7] | Zhang Fan . . Journal of Kunming Medical University, |
[8] | Tian Jin Tao . . Journal of Kunming Medical University, |
[9] | Hu Ji Lin . . Journal of Kunming Medical University, |
[10] | Meng Li Hong . . Journal of Kunming Medical University, |
[11] | Huang Xiao Bin . . Journal of Kunming Medical University, |
[12] | Yang Yu Ling . . Journal of Kunming Medical University, |
[13] | Bi Xiao Fang . . Journal of Kunming Medical University, |
[14] | Li Jing Tao . P38-一种信号分子在神经系统疾病中的作用. Journal of Kunming Medical University, |
[15] | Liu Ao Xiang . . Journal of Kunming Medical University, |
[16] | Li Yu . . Journal of Kunming Medical University, 2011, 32(02): 1-1. |
[17] | . BDNF Expression in the Central Nervous System of Tree Shrews(Tupaia Belangeri Chinensis). Journal of Kunming Medical University, |
[18] | Zhou Lei . . Journal of Kunming Medical University, |
[19] | Yang Xiao Wen . . Journal of Kunming Medical University, |
[20] | Ding Peng . . Journal of Kunming Medical University, |